Alan S. Gamis
Children's Mercy Hospital(US)The University of Kansas Cancer Center(US)Mercy Hospital(US)Mercy Research(US)Mercy Hospital(US)University of Missouri–Kansas City(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Protein Degradation and Inhibitors, Hematopoietic Stem Cell Transplantation, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions(2017)857 cited
- → Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531(2014)461 cited
- → Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group(2012)291 cited
- → Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis(2003)236 cited
- → Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971(2011)228 cited
- → AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia